Someone’s Betting Big Against XRP Right Now
Xaif suggested that the investor is a liquidation hunter. The total position now sits at $2.18 million notional with $436.4K in margin. The liquidation price is $1.7760. The wallet is 100% short-biased with no open long positions.
The short opened on Aug 23 at 11:07 PM at an entry of $1.5157, with the addition bringing the average entry to $1.5140. At the time of the video, the mark price was $1.5062, putting the position slightly in profit.
The Trader Behind the Position
This is not a random wallet. It holds a 70% win rate across 92 transactions, a Sharpe ratio of 1.62, and a profit factor of 5.98. The wallet averaged +$9.6K daily P&L over the past 30 days, realizing +$28.9K in that period. Its best day was Aug 20 at +$17.0K. Its worst was Aug 23 at -$3.3K.
The largest single XRP win on record for this wallet was +$15.1K. The largest loss was -$5.7K. The trader executes an average of 3.0 trades per day.
XRP’s Recent Price Movement
XRP had a sharp week. The token bottomed near $0.9862 before surging over 50% to about $1.51. The rally drew fuel from multiple sources. The US Treasury announced on Aug 19 that it would double its long-term bond buyback operations from $2 billion to at least $4 billion per operation, effective Sep 9. That pushed the 30-year yield down from a 19-year high of 5.337% and lifted risk appetite across crypto markets.
XRP led the altcoin rally. Spot XRP ETFs recorded $39.78 million in net inflows for the week ending Aug 21, their strongest week since May 2026. A White House crypto summit attended by Ripple’s CEO added further momentum.
What Comes Next?
The wallet’s track record demands attention. Whether the short pays off depends on whether XRP holds above $1.50 or gives back more of its gains.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Trades Around $86K as FOMO Hits Highest Level Since 2024

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions
ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.
Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.
The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.
SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.
The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).
